Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clin Epigenetics.
Style de citation ChicagoWang, Hao, Ran Peng, Junjie Wang, Zelian Qin, et Lixiang Xue. "Circulating MicroRNAs As Potential Cancer Biomarkers: The Advantage and Disadvantage." Clin Epigenetics 2018.
Style de citation MLAWang, Hao, et al. "Circulating MicroRNAs As Potential Cancer Biomarkers: The Advantage and Disadvantage." Clin Epigenetics 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.